Grantham, Mayo, Van Otterloo & Co (GMO)’s L3Harris LHX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$797K Sell
2,741
-302
-10% -$96K ﹤0.01% 538
2026
Q1
$1.05M Buy
3,043
+309
+11% +$108K ﹤0.01% 503
2025
Q4
$803K Sell
2,734
-467
-15% -$135K ﹤0.01% 536
2025
Q3
$978K Buy
+3,201
New +$875K ﹤0.01% 486
2020
Q3
Sell
-6,320
Closed -$1.07M 800
2020
Q2
$1.07M Sell
6,320
-14,400
-69% -$2.71M 0.01% 520
2020
Q1
$3.73M Buy
20,720
+7,000
+51% +$1.43M 0.03% 282
2019
Q4
$2.71M Buy
+13,720
New +$2.75M 0.02% 357
2015
Q3
Sell
-180,000
Closed -$13.8M 581
2015
Q2
$13.8M Buy
+180,000
New +$14.3M 0.04% 164
2014
Q1
Sell
-9,989
Closed -$697K 605
2013
Q4
$697K Sell
9,989
-2,885
-22% -$183K ﹤0.01% 500
2013
Q3
$763K Sell
12,874
-10,339
-45% -$576K ﹤0.01% 492
2013
Q2
$1.14M Buy
+23,213
New +$1.1M ﹤0.01% 448

Other funds holding LHX

Grantham, Mayo, Van Otterloo & Co (GMO)'s LHX Position: Q2 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) reduced its L3Harris (LHX) stake by 9.9% in Q2 2026, selling an estimated $96K and leaving 2,741 shares worth $797K. The position accounts for ﹤0.01% of the portfolio, ranked #538.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in LHX in Q2 2013 and has held it in 11 quarters since. The position peaked at $13.8M in Q2 2015. 1,685 funds tracked by Wall St. Rank hold LHX as of Q2 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 2,741 shares of L3Harris worth $797K as of Q2 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 302 L3Harris shares in Q2 2026, an estimated $96K.
  • L3Harris made up ﹤0.01% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q2 2026, its #538 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in L3Harris in Q2 2013 and has held it in 11 quarters since.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s L3Harris position peaked at $13.8M in Q2 2015.
  • 1,685 funds tracked by Wall St. Rank held L3Harris as of Q2 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.